Data from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy

MLA

Annie L.M. Cheung, et al. Data from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6521543.

APA

Annie L.M. Cheung, Qing Yu He, Yuk Yin Li, Ruslan Novosyadlyy, Dale L. Ludwig, Kwok Wah Chan, Sai Wah Tsao, & Bin Li. (2023). Data from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy. https://doi.org/10.1158/1078-0432.c.6521543

Chicago

Annie L.M. Cheung, Qing Yu He, Yuk Yin Li, Ruslan Novosyadlyy, Dale L. Ludwig, Kwok Wah Chan, Sai Wah Tsao, and Bin Li. 2023. “Data from Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance—Implications for IGF-II and IGF-IR–Targeted Therapy,” March. doi:10.1158/1078-0432.c.6521543.